South Wales, Oct. 24 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "DHANIRA" on Oct. 10. The details about the trademark application no. UK00004276352 published in the journal no. 2025/043 (Oct. 24).
With HGF Limited as representative, Kiniksa Pharmaceuticals, GmbH filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Anti-inflammatories; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare diseases and disorders.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004276352
Disclaimer: Curated by HT Syndication.
